Navigation Links
Cold Chain Management Firm Modality Solutions Releases Timely White Paper on Transport Simulation Methodology
Date:8/12/2020

Modality Solutions, a biopharmaceutical cold chain validation engineering firm, is making available for free its new white paper – Simulated Transport Methodologies. Regulatory expectations are driving the need to incorporate concurrent transport simulation testing into today’s biologics licensing application (BLA). In response, Modality Solutions shares an explanation of best-in-class methodologies for today’s biotechnology and biopharmaceutical industries.

The simulation transport guide’s goal is to detail how simulated transport is a valuable technique to determine the physical stability of drug product protein solutions, including vaccines, monoclonal antibodies, antibody-drug conjugates (ADCs), and gene therapies. Large molecule drug products may be susceptible to degradation when exposed to common transport hazards. Simulation testing exposes the product to the concurrent combination of these hazards at worst-case edges of your operating space in the global supply chain. Unlike ASTM-based testing, the hazards are applied with realistic durations and intensities that reflect the supply chain’s risks.

The Simulated Transport Methodologies white paper explains how a transport simulation approach is the most reliable way to create the real-time hazard levels experienced in the cold chain logistics network:

  • The simulation testing concurrently exposes the product to the five major transport hazards affecting drug product quality: shock, vibration, temperature, pressure, and humidity at the edges of your operating space.
  • Analytical results from samples exposed to worst-case transportation hazards demonstrate product robustness during simulated shipping.
  • Non-accelerated profiles are selected because they reflect the energy levels and intensities in the supply chain. The goal is not to accelerate the testing, but to replicate all the hazards in transit.

“An understanding of these methodologies is vital to ensure the simulated transport hazards reflect the actual cold chain for each therapy,” explains Modality Solutions President Gary Hutchinson. “If correctly planned and executed to be included in the BLA, analytical results from samples exposed to concurrent transport simulation are considered industry best practice.”

Modality Solutions’ unique Advantage Transport Simulation Laboratory provides the engineering platform for a biopharmaceutical cold chain network to test drug product formulation development and stability better than any “real-world” shipping study in the marketplace.

Click here to download the Simulated Transport Methodologies White Paper.

With Modality Solutions, three types of firms–cold chain regulatory filing authority, logistics network operations, and experienced staffing firm combine as a single source for cold chain management integration for the life sciences industry.

To learn more about Modality Solutions, visit https://www.modality-solutions.com.

About Modality Solutions, LLC
Founded in 2011, Modality Solutions, a leading biopharmaceutical cold chain engineering firm, specializes in integrating cold chain operations, developing transport validation strategies, supporting global regulatory applications, and global clinical trial operations. By combining the best practices of process validation, systems qualification, and risk assessment, Modality Solutions has earned the reputation of ensuring regulatory compliance, drug product quality, and patient safety. As a 2019 Inc. 5000 company, Houston Business Journal Fast 100, Entrepreneur 360™, and Forbes Technology Council company, Modality Solutions’ team of engineers are experts at delivering cold chain thermal packaging design and qualification, conducting transport simulation testing with its Advantage Transport Simulation Laboratory™, and designing controlled environment-logistics solutions. For more information, visit https://www.modality-solutions.com.

Read the full story at https://www.prweb.com/releases/cold_chain_management_firm_modality_solutions_releases_timely_white_paper_on_transport_simulation_methodology/prweb17312189.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. Cold Chain Management Firm Modality Solutions Adds Carson Dickey to Its Consulting Engineer Team
2. Modality Solutions Webinar Replay: Cold Chain Validation Best Practices Including CAR T-cell and ADC Immunotherapies
3. Modality Solutions is a Silver Sponsor and Cold Chain Workshop Presenter at the Biomanufacturing World Summit Conference
4. Cold Chain Management Firm Modality Solutions Promotes Robert Battista to Senior Consulting Engineer
5. Cold Chain Experts Modality Solutions Recognized as an Inc. Verified Company
6. TrakCel and Quick partner to provide industry-leading digital supply chain IT solution for cell and gene therapies
7. USARAD Holdings, Inc. Including Its SecondOpinions.Com® Division Makes History By Obtaining Blockchain Based Radiology Interpretations Via Cryptocurrency
8. Global ID Group Sponsors Complimentary Webinar Featuring a Better Way to Assess Supply Chain Risks
9. FoodChain ID, Technical Administrator for the Non-GMO Project, Verifies Its 50,000th Product
10. Aerocom Healthcare Introduces Chain-of-Custody Pneumatic Tube System at ASHP Midyear
11. Cold Chain Technologies Promotes Richard Formato to Principal Technologist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2020)... TORONTO (PRWEB) , ... July 22, 2020 , ... Join ... and John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... is the regulating body in China for drugs and medical devices. Specifically, for medical ...
(Date:7/18/2020)... Ohio (PRWEB) , ... July 16, 2020 , ... ... data solutions to aid in the early detection and prevention of high-burden diseases, ... to enable US-based hospitals and healthcare organizations to utilize existing data in order ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now ... up to 200 million stem cells. Depending on the patient's condition, treatment may be ... US will die having some form of Alzheimers dementia, and the incidence continues to ...
Breaking Biology Technology:
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... company announced a new partnership with medical equipment manufacturer, Spectrum Solutions, to provide ... clients to strengthen their laboratory supply chain for more than 10 years. Early ...
(Date:7/18/2020)... ... 2020 , ... Commercial launch readiness is a critical stage in a product ... or vaccine, the global economic downturn will only increase price pressures overall for the ... capturing full value from every product launch is critical. However, history shows that only ...
(Date:7/2/2020)... Md. (PRWEB) , ... July ... ... Molecular Biology Systems, B.V. (MBS) has announced a publication detailing the use ... one-step reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The article, ...
Breaking Biology News(10 mins):